Private equity has rightly made commercial due diligence a core part of how deals get done. Across the board, revenue growth is now the main source of value creation, so understanding the commercial side of a business is non-negotiable. But still, most CDDs concentrate on market conditions and upside potential, not on the harder question:
“Is this company actually commercially fit enough to deliver the growth we’re paying for?”
The hard truth is that in most cases, yes, there is a market potential – but exactly that missing assessment is what creates distorted valuations and overconfident deal theses.
The one-sided coin: Market Attractiveness and Upside Potential
Far too often, traditional CDDs focus on two domains that describe the external opportunity landscape.
a) Market attractiveness: total addressable market, growth rate, competitive intensity, macro tailwinds, and white-space pockets etc.
b) Upside potential: market share expansion, cross-sell and up-sell levers, pricing headroom, adjacent segments, and geographic expansion.
While relevant, these analyses simply answer whether the opportunity exists. They do not answer whether the company has the internal commercial machinery to capture it, or what to actually do about it. Most diligence teams implicitly assume capability, even when capability is THE VARIABLE that determines whether the revenue curve will be steep, flat, or fictitious.
The deferred question: Commercial fitness
Sadly, the critical question – How fit is the company to actually capture that growth? – is frequently postponed until post-close planning. Yet this question is the strongest predictor of:
- the shape and speed of the revenue ramp
- the margin impact of capability gaps
- the scale of investments required to close those gaps
- the real timing and feasibility of the upside thesis
A company with weak commercial fitness will require heavy investment in segmentation, pricing, sales enablement, messaging, channel redesign, or portfolio simplification before any growth materializes. Ignoring this in CDD creates a valuation built on execution assumptions that do not match reality.
The Lost Grail: A real definition of commercial fitness
Commercial fitness is not a single metric, nor a stringent, formulaic analysis. It is the combined strength of interdependent disciplines that in interplay dictates the traction of the commercial engine (the exact levers will change depending on the maturity and industry of the target company). Typically these include:
- Segmentation and targeting based on economic potential
- Positioning and value messaging that differentiate and convert
- Price setting grounded in willingness-to-pay and elasticity
- Price realization enforced through governance and frontline behavior
- Channel strategy aligned with buyer economics and reach
- Route to market that matches customer journeys and cost-to-serve
- Portfolio architecture that clarifies value and avoids complexity
- Promotional and demand-generation engines that scale effectively
These disciplines define whether the “upside” identified in diligence is accessible or imaginary. A market with strong tailwinds does not compensate for weak pricing execution. A portfolio with expansion potential does not matter if the commercial engine cannot convey differentiated value.
Opportunity is irrelevant without capability.
Why the blind spot persists
Most CDD teams are staffed by business generalists who can analyze markets but cannot assess commercial capability in a diagnostic, benchmarked way. Under time pressure, they gravitate toward what is easily quantified. Fitness demands expert interrogation of frontline processes, discount patterns, messaging coherence, sales economics, and channel design – areas that require specialized operators, feet on the ground, and the ability to work with incomplete or muddy data points.
As a result, commercial fitness becomes a “Phase 2 activity”, despite being the most important driver of valuation realism. The cost shows up post-close, when investors suddenly realize the company lacks segmentation discipline, pricing governance, coherent route-to-market design, or the commercial hygiene required to accelerate. At that point, the price is locked, expectations are fixed, and the capability gaps translate into expensive programs and delayed revenue.
The cost of finding out too late
Pushing the assessment into value-creation planning is already too late.
Once the deal is done, the forecast is committed, the growth story is public, the leadership team expects acceleration, and the commercial engine must perform instantly, despite needing repair.
This mismatch creates a recurring industry pattern: investors buy on the basis of opportunity, then spend 12-18 months discovering that the company cannot execute the opportunity without fundamental rebuilds. The result is a drag on value realization that could have been identified – and priced – before closing.
Kvadrant’s Approach: Bringing Fitness Into CDD
The only remedy is to embed commercial fitness analysis directly into CDD. This is not a matter of adding more slides. It requires integrating real specialists from day one.
At Kvadrant Consulting, our teams always include experts from our go-to-market excellence and commercial transformation practices. They run focused diagnostic sprints covering pricing architecture, discount governance, segmentation logic, sales model productivity, portfolio design, channel economics, and pipeline conversion. The goal is to quantify execution readiness before the deal is priced, not after.
Traditional generalist-led CDD typically identifies potential and opportunity. Our approach evaluates accessibility. That distinction changes the credibility of the deal thesis and the reliability of the value-creation plan. Most PE firms think they are conducting commercial due diligence. In reality, they are conducting market due diligence and assuming commercial capability.
I believe that the secret sauce is found in deep functional expertise – being able to systemically evaluate the value-capturing potential of a company, and to be frank, the market diligence is in the age of AI… a commodity?
Without assessing commercial fitness, every growth thesis is only half a thesis.
Sixten leads our Transactions & Strategy practice, partnering with private equity and corporate clients on target identification, commercial due diligence, value realization, company and commercial strategy, and exit optimization.
Jonathan specializes in designing, driving and implementing critical marketing transformations across the marketing landscape, including brand and thought leadership, solution marketing, product launch and go-to-market.
